Boston Trust Walden’s Diageo DEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
5,846
-1,125
-16% -$90.8K ﹤0.01% 342
2026
Q1
$519K Sell
6,971
-335
-5% -$29.2K ﹤0.01% 325
2025
Q4
$630K Sell
7,306
-681
-9% -$62.7K ﹤0.01% 310
2025
Q3
$762K Sell
7,987
-659
-8% -$69.2K 0.01% 298
2025
Q2
$872K Sell
8,646
-1,385
-14% -$150K 0.01% 283
2025
Q1
$1.05M Sell
10,031
-16,655
-62% -$1.88M 0.01% 275
2024
Q4
$3.39M Sell
26,686
-483
-2% -$61.4K 0.02% 237
2024
Q3
$3.81M Sell
27,169
-1,817
-6% -$236K 0.03% 233
2024
Q2
$3.65M Sell
28,986
-2,440
-8% -$336K 0.03% 232
2024
Q1
$4.67M Sell
31,426
-29,125
-48% -$4.26M 0.03% 227
2023
Q4
$8.82M Sell
60,551
-1,122
-2% -$166K 0.07% 201
2023
Q3
$9.2M Buy
61,673
+1,683
+3% +$282K 0.08% 197
2023
Q2
$10.4M Sell
59,990
-1,290
-2% -$230K 0.09% 195
2023
Q1
$11.1M Sell
61,280
-201
-0.3% -$35.5K 0.1% 193
2022
Q4
$11M Sell
61,481
-350
-0.6% -$61.4K 0.1% 196
2022
Q3
$10.5M Sell
61,831
-100
-0.2% -$17.9K 0.1% 195
2022
Q2
$10.8M Sell
61,931
-1,590
-3% -$302K 0.1% 197
2022
Q1
$12.9M Buy
63,521
+94
+0.1% +$18.8K 0.11% 192
2021
Q4
$14M Sell
63,427
-125
-0.2% -$25.6K 0.11% 195
2021
Q3
$12.3M Sell
63,552
-165
-0.3% -$32K 0.11% 198
2021
Q2
$12.2M Sell
63,717
-13,175
-17% -$2.45M 0.11% 202
2021
Q1
$12.6M Sell
76,892
-11,500
-13% -$1.88M 0.12% 199
2020
Q4
$14M Buy
88,392
+1,070
+1% +$160K 0.15% 187
2020
Q3
$12M Sell
87,322
-4,375
-5% -$603K 0.15% 181
2020
Q2
$12.3M Buy
91,697
+10,425
+13% +$1.43M 0.17% 181
2020
Q1
$10.3M Sell
81,272
-6,100
-7% -$915K 0.16% 174
2019
Q4
$14.7M Sell
87,372
-225
-0.3% -$36.6K 0.17% 173
2019
Q3
$14.3M Buy
87,597
+150
+0.2% +$25.1K 0.18% 169
2019
Q2
$15.1M Buy
87,447
+41
+0% +$6.89K 0.2% 151
2019
Q1
$14.3M Buy
87,406
+1,000
+1% +$153K 0.19% 150
2018
Q4
$12.3M Sell
86,406
-50
-0.1% -$7.03K 0.19% 152
2018
Q3
$12.2M Buy
86,456
+315
+0.4% +$45.2K 0.17% 167
2018
Q2
$12.4M Sell
86,141
-450
-0.5% -$64.4K 0.18% 162
2018
Q1
$11.7M Sell
86,591
-150
-0.2% -$20.9K 0.18% 163
2017
Q4
$12.7M Sell
86,741
-210
-0.2% -$28.9K 0.19% 157
2017
Q3
$11.5M Buy
86,951
+5,425
+7% +$701K 0.18% 160
2017
Q2
$9.77M Buy
81,526
+2,111
+3% +$251K 0.16% 174
2017
Q1
$9.18M Sell
79,415
-6,150
-7% -$690K 0.14% 184
2016
Q4
$8.89M Sell
85,565
-1,675
-2% -$176K 0.14% 183
2016
Q3
$10.1M Buy
87,240
+25,655
+42% +$2.93M 0.17% 173
2016
Q2
$6.95M Sell
61,585
-19,820
-24% -$2.14M 0.12% 195
2016
Q1
$8.78M Sell
81,405
-53,565
-40% -$5.67M 0.15% 185
2015
Q4
$14.7M Sell
134,970
-305
-0.2% -$34.4K 0.27% 144
2015
Q3
$14.6M Sell
135,275
-25,825
-16% -$2.87M 0.24% 158
2015
Q2
$18.7M Sell
161,100
-11,865
-7% -$1.35M 0.29% 151
2015
Q1
$19.1M Sell
172,965
-8,920
-5% -$1.03M 0.28% 148
2014
Q4
$20.8M Sell
181,885
-3,100
-2% -$360K 0.31% 130
2014
Q3
$21.3M Sell
184,985
-9,765
-5% -$1.18M 0.33% 136
2014
Q2
$24.8M Sell
194,750
-12,442
-6% -$1.57M 0.36% 127
2014
Q1
$25.8M Sell
207,192
-7,612
-4% -$949K 0.38% 121
2013
Q4
$28.4M Sell
214,804
-4,055
-2% -$518K 0.42% 108
2013
Q3
$27.8M Sell
218,859
-4,175
-2% -$522K 0.43% 112
2013
Q2
$25.6M Buy
+223,034
New +$27M 0.41% 118

Other funds holding DEO

Boston Trust Walden's DEO Position: Q2 2026 in Review

Boston Trust Walden reduced its Diageo (DEO) stake by 16% in Q2 2026, selling an estimated $90.8K and leaving 5,846 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Boston Trust Walden first reported a position in DEO in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.4M in Q4 2013. 263 funds tracked by Wall St. Rank hold DEO as of Q2 2026.

  • Boston Trust Walden held 5,846 shares of Diageo worth $470K as of Q2 2026.
  • Boston Trust Walden sold 1,125 Diageo shares in Q2 2026, an estimated $90.8K.
  • Diageo made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #342 holding.
  • Boston Trust Walden first reported a position in Diageo in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Diageo position peaked at $28.4M in Q4 2013.
  • 263 funds tracked by Wall St. Rank held Diageo as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.